Evaluation of angiogenic inhibitors with an in vivo quantitative angiogenesis method using agarose microencapsulation and mouse hemoglobin enzyme-linked immunosorbent assay

Japanese Journal of Cancer Research

Volumn 87, Issue 9, 1996, Pages 952-957

  Okada, Naoki ^a   Fushimi, Mariko ^a   Nagata, Yuriko ^a   Fukunaga, Tomoko ^a   Tsutsumi, Yasuo ^a   Nakagawa, Shinsaku ^a   Mayumi, Tadanori ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Agarose microencapsulation; Angiogenic inhibitor; Mouse hemoglobin ELISA; Tumor angiogenesis

Indexed keywords

AGAROSE; ANGIOGENESIS INHIBITOR; HEMOGLOBIN; HEPARIN; HYDROCORTISONE; MEDROXYPROGESTERONE ACETATE; PENTOSAN POLYSULFATE; PREGNANE DERIVATIVE; SURAMIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TUMOR VASCULARIZATION;

EID: 0029846980     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb02125.x     Document Type: Article

References (29)

1. Algire, G. H., Legallais, F. Y. and Park, H. D. Vascular reactions of normal and malignant tissues in vivo. II. The vascular reactions of normal and neoplastic tissues of mice to a bacterial polysaccharide from Serratia marcescens (Bacillus prodigiosus) culture filtrates. J. Natl. Cancer Inst., 8, 53-62 (1947).
2. Folkman, J. and Ingber, D. E. Angiostatic steroids: method of discovery and mechanism of action. Ann. Surg., 206, 374-383 (1987).
3. Goldie, I. The synovial microvascular derangement in rheumatoid arthritis and osthoarthritis. Acta Orthop. Scand., 40, 751-764 (1970).
4. Kirsner, R. S. and Eaglstein W. H. The wound healing process. Dermatol. Clin., 11, 629-640 (1993).
5. Heldin, C.-H., Usuki, K. and Miyazono, K. Platelet-derived endothelial cell growth factor. J. Cell. Biochem., 47, 208-210 (1991).
6. Crum, R., Szabo, S. and Folkman, J. A new class of steroids inhibits angiogenesis in the presence of heparin or heparin fragment. Science, 230, 1375-1378 (1985).
7. Ingber, D. E., Madri, J. A. and Folkman, J. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology, 119, 1768-1775 (1986).
8. Wilks, J. W., Scott, P. S., Vrba, L. K. and Cocuzza, J. M. Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin. Int. J. Radiat. Biol., 60, 73-77 (1991).
9. Okada, N., Fushimi, M., Nagata, Y., Fukunaga, T., Tsutsumi, Y., Nakagawa, S. and Mayumi, T. A quantitative in vivo method of analyzing human tumor-induced angiogenesis in mice using agarose microencapsulation and hemoglobin enzyme-linked immunosorbent assay. Jpn. J. Cancer Res., 86, 1182-1188 (1995).
10. Okada, N., Kaneda, Y., Miyamoto, H., Yamamoto, Y., Mizuguchi, H., Tsutsumi, Y., Nakagawa, S. and Mayumi, T. Selective enhancement by tumor necrosis factor-α of vascular permeability of new blood vessels induced with agarose hydrogel-entrapped Meth-A fibrosarcoma cells. Jpn. J. Cancer Res., 87, 831-836 (1996).
11. Lee, J. K., Choi, B., Sobel, R. A., Chiocca, E. A. and Martuza, R. L. Inhibition of growth and angiogenesis of human neorofibrosarcoma by heparin and hydrocortisone. J. Neurosurg., 73, 429-435 (1990).
12. Li, W. W., Casey, R., Gonzalez, E. M. and Folkman, J. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization. Invest. Ophthalmol. Visual Sci., 32, 2898-2905 (1991).
13. Gagliardi, A., Hadd, H. and Collins, D. C. Inhibition of angiogenesis by suramin. Cancer Res., 52, 5073-5075 (1992).
14. Gross, J., Azizkhan, R. G., Biswas, C., Bruns, R. R., Hsieh, D. S. T. and Folkman, J. Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc. Natl. Acad. Sci. USA, 78, 1176-1180 (1981).
15. Oikawa, T., Hiragun, A., Yoshida, Y., Ashino-Fuse, H., Tominaga, T. and Iwaguchi, T. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a] anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition. Cancer Lett., 43, 85-92 (1988).
16. Fujimoto, J., Hosoda, S., Fujita, H. and Okada, H. Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invasion Metastasis, 9, 269-277 (1989).
17. Fujimoto, J., Hosoda, S., Fujita, H. and Okada, H. Inhibition of tumor angiogenesis activity in C3H mouse mammary tumor by medroxyprogesterone acetate. Acta Obstet. Gynaecol. Jpn., 41, 77-82 (1989).
18. Ashino-Fuse, H., Takano, Y., Oikawa, T., Shimamura, M. and Iwaguchi, T. Medroxyprogesterone acetate, an anticancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells. Int. J. Cancer, 44, 859-864 (1989).
19. Zugmaier, G., Lippman, M. E. and Wellstein, A. Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J. Natl. Cancer Inst., 84, 1716-1724 (1992).
20. Pienta, K. J., Murphy, B. C., Isaacs, W. B., Isaacs, J. T. and Coffey, D. S. Effect of pentosan, a novel cancer chemotherapeutic agent, on prostate cancer cell growth and motility. Prostate, 20, 233-241 (1992).
21. Wellstein, A., Zugmaier, G., Califano III, J. A., Kern, F., Paik, S. and Lippman, M. E. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J. Natl. Cancer Inst., 83, 716-720 (1991).
22. Pesenti, E., Sola, F., Mongelli, N., Grandi, M. and Spreafico, F. Suramin prevents neovascularisation and tumor growth through blocking of basic fibroblast growth factor activity. Br. J. Cancer, 66, 367-372 (1992).
23. Takano, S., Gately, S., Neville, M. E., Herblin, W. F., Gross, J. L., Engelhard, H., Perricone, M., Eidsvoog, K. and Brem, S. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res., 54, 2654-2660 (1994).
24. Nilsson, K., Scheirer, W., Merten, O. W., Ostberg, L., Liehl, E., Katinger, H. W. D. and Mosbach, K. Entrapment of animal cells for production of monoclonal antibodies and other biomolecules. Nature, 302, 629-630 (1983).
25. Nilsson, K., Scheirer, W., Katinger, H. W. D. and Mosbach, K. Entrapment of animal cells. Methods Enzymol., 135, 399-410 (1987).
26. Norrby, K. and Sorbo, J. Heparin enhances angiogenesis by a systemic mode of action. Int. J. Exp. Pathol., 73, 147-155 (1992).
27. Cariou, R., Harousseau, J. L. and Tobelem, G. Inhibition of human endothelial cell proliferation by heparin and steroids. Cell Biol. Int. Rep., 12, 1037-1047 (1988).
28. Sakamoto, N. and Tanaka, N. G. Mechanism of the synergistic effect of heparin and cortisone against angiogenesis and tumor growth. Cancer J., 2, 9-13 (1988).
29. Maragoudakis, M. E., Sarmonika, M. and Panoutsacopoulou, M. Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system. J. Pharmacol. Exp. Ther., 251, 679-682 (1989).